Your browser doesn't support javascript.
loading
#2714, a novel active inhibitor with potent G2/M phase arrest and antitumor efficacy in preclinical models.
Lu, Wen-Jie; Peng, Wen; Sun, Qian-Qian; Li, Yong-Huai; Chen, Bo; Yu, Luo-Ting; Xu, You-Zhi; Wang, Si-Ying; Zhao, Ying-Lan.
Affiliation
  • Lu WJ; 1School of Basic Medicine, Anhui Medical University, Hefei, 230032 China.
  • Peng W; Department of Oncology, The People's Hospital of Guizhou Province, Guiyang, 550004 China.
  • Sun QQ; 3State Key Laboratory of Biotherpay, Cancer Center, West China Hospital, Sichuan University, Chengdu, 610041 China.
  • Li YH; 1School of Basic Medicine, Anhui Medical University, Hefei, 230032 China.
  • Chen B; 4Department of Respiratory Disease, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230022 China.
  • Yu LT; 5Department of Gastrointestinal Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230022 China.
  • Xu YZ; 3State Key Laboratory of Biotherpay, Cancer Center, West China Hospital, Sichuan University, Chengdu, 610041 China.
  • Wang SY; 1School of Basic Medicine, Anhui Medical University, Hefei, 230032 China.
  • Zhao YL; 1School of Basic Medicine, Anhui Medical University, Hefei, 230032 China.
Cell Death Discov ; 4: 24, 2018 Dec.
Article in En | MEDLINE | ID: mdl-29531821
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Cell Death Discov Year: 2018 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Cell Death Discov Year: 2018 Type: Article